1887

Abstract

We identified a strain with high-level resistance to azithromycin (MIC>256 mg l), NSH1, isolated from nasopharyngeal swab samples from an inpatient with acute bronchitis in a Japanese hospital in 2011 and determined its mechanism of macrolide–lincosamide resistance. Antimicrobial susceptibility of strains was determined using the Etest and agar dilution methods. Mutations in the four 23S rRNA alleles, the ribosomal proteins L4 and L22, and methylase genes (B) and (F) were tested by PCR and/or sequencing. The efflux system was examined using appropriate inhibitors. Transformation experiments were performed using DNA amplicons of the 23S rRNA gene of strain NSH1. This strain showed high-level resistance to erythromycin, clarithromycin, azithromycin, clindamycin (MICs>256 mg l) and josamycin (MIC = 128 mg l), and contained the A2058T mutation ( numbering) in four of the 23S rRNA alleles. Mutation of the ribosomal proteins and overproduction of the efflux system were not observed, and methylase genes were not detected. When amplified DNA containing the single A2058T mutation was transformed into strains, transformants with three A2058T-mutated 23S rRNA alleles showed high-level resistance to macrolide–lincosamide, similar to strain NSH1. In contrast, transformants with two A2058T-mutated 23S rRNA alleles showed low-level MICs (azithromycin: 0.38–0.5 mg l). Thus, a single A2058T mutation occurring in at least three 23S rRNA alleles confers high-level resistance to 14-, 15- and 16-membered macrolides and lincosamides in possessing four 23S rRNA alleles. This study represents the first evidence, to our knowledge, of this effect in .

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.046706-0
2012-10-01
2019-10-15
Loading full text...

Full text loading...

/deliver/fulltext/jmm/61/10/1435.html?itemId=/content/journal/jmm/10.1099/jmm.0.046706-0&mimeType=html&fmt=ahah

References

  1. Chisholm S. A., Dave J., Ison C. A.. ( 2010;). High-level azithromycin resistance occurs in Neisseria gonorrhoeae as a result of a single point mutation in the 23S rRNA genes. . Antimicrob Agents Chemother 54:, 3812–3816. [CrossRef][PubMed]
    [Google Scholar]
  2. CLSI ( 2011;). Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement M100-S21. . Wayne, PA:: Clinical and Laboratory Standards Institute;.
  3. de Vries S. P. W., van Hijum S. A., Schueler W., Riesbeck K., Hays J. P., Hermans P. W. M., Bootsma H. J.. ( 2010;). Genome analysis of Moraxella catarrhalis strain RH4, a human respiratory tract pathogen. . J Bacteriol 192:, 3574–3583. [CrossRef][PubMed]
    [Google Scholar]
  4. Li B. B., Wu C. M., Wang Y., Shen J. Z.. ( 2011;). Single and dual mutations at positions 2058, 2503 and 2504 of 23S rRNA and their relationship to resistance to antibiotics that target the large ribosomal subunit. . J Antimicrob Chemother 66:, 1983–1986. [CrossRef][PubMed]
    [Google Scholar]
  5. Liu Y., Zhao C., Zhang F., Chen H., Chen M., Wang H.. ( 2012;). High prevalence and molecular analysis of macrolide-nonsusceptible Moraxella catarrhalis isolated from nasopharynx of healthy children in China. . Microb Drug Resist 18:, 417–426. [CrossRef][PubMed]
    [Google Scholar]
  6. Matsuoka M., Narita M., Okazaki N., Ohya H., Yamazaki T., Ouchi K., Suzuki I., Andoh T., Kenri T.. & other authors ( 2004;). Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. . Antimicrob Agents Chemother 48:, 4624–4630. [CrossRef][PubMed]
    [Google Scholar]
  7. Murphy T. F., Parameswaran G. I.. ( 2009;). Moraxella catarrhalis, a human respiratory tract pathogen. . Clin Infect Dis 49:, 124–131. [CrossRef][PubMed]
    [Google Scholar]
  8. Roberts M. C., Sutcliffe J., Courvalin P., Jensen L. B., Rood J., Seppala H.. ( 1999;). Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. . Antimicrob Agents Chemother 43:, 2823–2830.[PubMed]
    [Google Scholar]
  9. Tait-Kamradt A., Davies T., Cronan M., Jacobs M. R., Appelbaum P. C., Sutcliffe J.. ( 2000;). Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. . Antimicrob Agents Chemother 44:, 2118–2125. [CrossRef][PubMed]
    [Google Scholar]
  10. Versalovic J., Shortridge D., Kibler K., Griffy M. V., Beyer J., Flamm R. K., Tanaka S. K., Graham D. Y., Go M. F.. ( 1996;). Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. . Antimicrob Agents Chemother 40:, 477–480.[PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.046706-0
Loading
/content/journal/jmm/10.1099/jmm.0.046706-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error